Trial intelligence / Profile preview

Oxygenation targets in COVID-19 patients with respiratory failure

NCT04425031Phase 4Completed

Sponsor
Aalborg University Hospital
Start
Aug 2020
Primary completion
Mar 2023
Modality
Inhalation Devices
Countries
3
01

Overview

A Phase 4 trial of oxygen in coronavirus disease 2019 (COVID-19), hypoxemic respiratory failure, sponsored by Aalborg University Hospital. Started Aug 2020; status: completed.

02

Drugs

oxygen
03

Conditions

coronavirus disease 2019 (COVID-19)hypoxemic respiratory failure

Beyond the preview

Go deeper on NCT04425031.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04425031.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call